Volume 95, Issue 2, Pages (February 2019)

Slides:



Advertisements
Similar presentations
How best to control salt overload in hypertension? - Dietetic? - Aligning dialysate sodium with patient's serum sodium -Prohibition of sodium profiling.
Advertisements

Evaluation and treatment of coronary artery disease in patients with end-stage renal disease Peter A. McCullough Kidney International Volume 67, Pages.
A.M. Thompson, T.G. Pickering  Kidney International 
Optimization of pre-ESRD care: The key to improved dialysis outcomes
Nina Vasavada, Rajiv Agarwal  Kidney International 
Volume 87, Issue 2, Pages (February 2015)
Volume 91, Issue 5, Pages (May 2017)
Beta blockers in the management of chronic kidney disease
Mineral and bone disorders in chronic kidney disease and end-stage renal disease patients: new insights into vitamin D receptor activation  Jordi Bover,
Plasma sodium and hypertension
Intensive hemodialysis—keeping the faith
Volume 70, Issue 8, Pages (October 2006)
Volume 92, Issue 1, Pages 2-3 (July 2017)
Volume 56, Pages S62-S66 (November 1999)
Elaine M. Spalding, Paul W. Chamney, Ken Farrington 
Seeing the sodium in a patient with hypernatremia
Intensive hemodialysis—keeping the faith
Prehypertension and chronic kidney disease: the ox or the plow?
Lucile Mercadal, Aziz Hamani, Bernard Béné, Thierry Petitclerc 
Volume 85, Issue 4, Pages (April 2014)
Erratum Regarding “Ultrasound Monitoring to Detect Access Stenosis in Hemodialysis Patients: A Systematic Review” (Am J Kidney Dis. 2008;51(4): ) 
Homocysteine and risk in end-stage renal disease: a matter of context
Urea for hyponatremia? Kidney International
Prediction of hypertension in chronic hemodialysis patients
The KDIGO guideline for dialysate calcium will result in an increased incidence of calcium accumulation in hemodialysis patients  Frank A. Gotch, Peter.
Volume 53, Issue 4, Pages (April 1998)
Comorbidity and confounding in end-stage renal disease
Volume 87, Issue 2, Pages (February 2015)
Volume 91, Issue 5, Pages (May 2017)
A New Era of Renal Denervation Trials for Patients With Hypertension?
N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment  Martina Franz, Wolfgang Woloszczuk, Walter.
Volume 70, Issue 11, Pages (December 2006)
Gary C.W. Chan, Sydney C.W. Tang  Kidney International 
Volume 89, Issue 5, Pages (May 2016)
Volume 91, Issue 5, Pages (May 2017)
Volume 71, Issue 6, Pages (March 2007)
Volume 70, Issue 12, Pages (December 2006)
Blood pressure targets in hemodialysis patients
Volume 84, Issue 4, Pages (October 2013)
Evolving concepts in the quantitative analysis of the determinants of the plasma water sodium concentration and the pathophysiology and treatment of the.
Volume 76, Issue 6, Pages (September 2009)
Effects of hemodialysis on cardiac function
Volume 67, Issue 1, Pages (January 2005)
Volume 69, Issue 3, Pages (February 2006)
Volume 93, Issue 1, Pages (January 2018)
Volume 71, Issue 6, Pages (March 2007)
Volume 87, Issue 1, Pages (January 2015)
Forearm reactive hyperemia and mortality in end-stage renal disease
The role of daily dialysis in the control of hyperphosphatemia
A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease  S. Susan Hedayati, Venkata Yalamanchili,
Volume 64, Issue 6, Pages (December 2003)
Joachim Böhler, M.D., Johannes Donauer, Frieder Keller 
Volume 64, Issue 2, Pages (August 2003)
Volume 67, Issue 1, Pages (January 2005)
Volume 63, Issue 2, Pages (February 2003)
Daily nocturnal home hemodialysis
Volume 62, Issue 3, Pages (September 2002)
Antonio Santoro, Elena Mancini  Kidney International 
Nina Vasavada, Rajiv Agarwal  Kidney International 
The Iranian model of living renal transplantation
Role of sodium in hemodialysis
Volume 58, Issue 2, Pages (August 2000)
Is it the low-protein diet or simply the salt restriction?
Is complement a target for therapy in renal disease?
Gregory Proctor, MD, Stuart Linas, MD 
Volume 68, Issue 1, Pages (July 2005)
Hisataka Kobayashi, Peter L. Choyke  Kidney International 
Non-invasive assessment of kidney oxygenation: a role for BOLD MRI
Associations of hemodialysis dose and session length with mortality risk in Australian and New Zealand patients  M.R. Marshall, B.G. Byrne, P.G. Kerr,
Optimization of pre-ESRD care: The key to improved dialysis outcomes
Presentation transcript:

Volume 95, Issue 2, Pages 296-309 (February 2019) Sodium and water handling during hemodialysis: new pathophysiologic insights and management approaches for improving outcomes in end-stage kidney disease  Bernard Canaud, Jeroen Kooman, Nicholas M. Selby, Maarten Taal, Susan Francis, Pascal Kopperschmidt, Andreas Maierhofer, Peter Kotanko, Jens Titze  Kidney International  Volume 95, Issue 2, Pages 296-309 (February 2019) DOI: 10.1016/j.kint.2018.09.024 Copyright © 2019 International Society of Nephrology Terms and Conditions

Figure 1 Total body sodium (Na) homeostasis and location. Kidney International 2019 95, 296-309DOI: (10.1016/j.kint.2018.09.024) Copyright © 2019 International Society of Nephrology Terms and Conditions

Figure 2 Role of sodium (Na) according to the new understanding of physiology. Kidney International 2019 95, 296-309DOI: (10.1016/j.kint.2018.09.024) Copyright © 2019 International Society of Nephrology Terms and Conditions

Figure 3 Pathophysiologic role of sodium (Na) accumulation and cross-talk. Kidney International 2019 95, 296-309DOI: (10.1016/j.kint.2018.09.024) Copyright © 2019 International Society of Nephrology Terms and Conditions

Figure 4 Precise management of sodium (Na) in hemodialysis (HD) patients. BIA, bioimpedance analysis; BP, blood pressure; BNP, brain natriuretic peptide; HR, heart rate; IVCD, intraventricular conduction delay; MBG, marinobufagenin; NT-proBNP, N-terminal prohormone of BNP; RBVC, relative blood volume change; US, ultrasound. Kidney International 2019 95, 296-309DOI: (10.1016/j.kint.2018.09.024) Copyright © 2019 International Society of Nephrology Terms and Conditions

Figure 5 Representative lower-limb 23Na magnetic resonance imaging (Na-MRI) features from 2 end-stage renal disease patients before and after hemodialysis (HD). (a) Patient with high sodium ion (Na+) removal after HD; ultrafiltration (UF) rate: 2.7 l. (b) Patient with low Na+ removal; UF rate: 3.5 l. Standards as represented by lower circles contain 10, 20, 30, and 40 mmol/l Na+. Reprinted from Dahlmann A, Dörfelt K, Eicher F, et al. Magnetic resonance-determined sodium removal from tissue stores in hemodialysis patients. Kidney Int. 2015;87:434–441,43 with permission from Elsevier. Copyright © 2015 International Society of Nephrology. Kidney International 2019 95, 296-309DOI: (10.1016/j.kint.2018.09.024) Copyright © 2019 International Society of Nephrology Terms and Conditions

Figure 6 Schematic representation of the electrolyte balancing control (EBC) module embedded in the hemodialysis (HD) monitoring device. The EBC integrates sodium and water handling capacity based on microsensoring ionic fluxes (inflow, outflow) and integrating sodium mass balance equivalent (overall: diffusive + convective [UF]) based on central processor unit (CPU) analytics. UF, ultrafiltration. Kidney International 2019 95, 296-309DOI: (10.1016/j.kint.2018.09.024) Copyright © 2019 International Society of Nephrology Terms and Conditions

Figure 7 Frequency distribution of intradialytic plasma sodium (iPNa) changes when dialyzing 30 patients either with a standard fixed dialysate sodium (Na) of 138 mmol/l (bars with horizontal lines) or with automated sodium control and a target of 0 diffusive transfer (bars with vertical lines). Each treatment phase consists of 100 hemodialysis (HD) sessions. The SD of the distribution was reduced by approximately 36% when switching from standard to sodium-controlled treatments. Kidney International 2019 95, 296-309DOI: (10.1016/j.kint.2018.09.024) Copyright © 2019 International Society of Nephrology Terms and Conditions

Figure 8 Potential benefits of a new technical solution, direct sodium (Na), and water control in hemodialysis patients for improving hemodialysis patient outcomes. MRI, magnetic resonance imaging. Kidney International 2019 95, 296-309DOI: (10.1016/j.kint.2018.09.024) Copyright © 2019 International Society of Nephrology Terms and Conditions